Market Forecast by Countries (United States, Canada), By Product (Lab Automation Equipment, Automated Microplate Readers, Automated ELISA Systems, Automated Nucleic Acid Purification Systems, Lab Automation Software & Informatics), By Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions), By End User (Biotechnology & Pharmaceutical Industries, Research & Academic Institutes, Hospitals & Diagnostic Laboratories, Forensic Laboratories, Environmental Testing Labs, Food & Beverage Industry) And Competitive Landscape
Product Code: ETC405201 | Publication Date: Aug 2022 | Updated Date: Jan 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 250 | No. of Figures: 50 | No. of Tables: 25 | |
Report Name | North America Lab Automation Market |
Forecast period | 2025-2031 |
CAGR | 8.5% |
Growing Sector | Biotechnology & Pharmaceutical |
North America Lab Automation Market report thoroughly covers the market by countries, product, application and end user. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
North America Lab Automation Market is experiencing significant growth and projected to attain more growth in the coming years due to advancements in technology and an increasing need for efficiency in laboratory processes. Automation solutions are being adopted rapidly across various sectors including pharmaceuticals, biotechnology, and clinical diagnostics. These solutions help in minimizing human error, enhancing workflow efficiency, and accelerating the process of research and development. The integration of robotics, artificial intelligence, and advanced software is revolutionizing lab operations, offering precise, reproducible, and scalable outcomes.
According to 6Wresearch, North America Lab Automation Market size is expected to grow at a CAGR of 8.5% during 2025-2031. Several factors are driving the growth of North America Lab Automation Market such as the increasing prevalence of chronic diseases necessitates rapid and accurate diagnostic solutions, pushing laboratories to adopt advanced automation technologies. Furthermore, the rising complexity of pharmaceutical R&D processes compels industries to integrate high-throughput screening and automated systems to enhance their drug discovery efforts efficiently. Additionally, stringent regulations and quality standards in clinical diagnostics mandate precise and reproducible testing procedures, where automation plays a crucial role in ensuring compliance. Apart from this, labour shortages and the need to minimize human error and operational costs encourage labs to invest in automated solutions.
However, North America Lab Automation Market faces few restraints such as high initial setup costs and the expense of maintaining advanced automation systems can be prohibitive for small and medium-sized laboratories, limiting their adoption. Additionally, the lack of skilled professionals proficient in operating and managing automated systems can pose a significant hurdle. Resistance to change within traditional laboratory settings also impedes the widespread implementation of automation technologies. Integrating new systems with existing laboratory infrastructure often involves complex processes and can result in operational disruptions. Furthermore, concerns regarding data privacy and security in automated systems can deter some laboratories from fully embracing these innovations.
The key players include Thermo Fisher Scientific, PerkinElmer, Danaher Corporation, Agilent Technologies, Beckman Coulter, Tecan Group. These companies focus on providing automated solutions for life science, molecular diagnostics, and applied markets, enhancing laboratory workflows.
North America Lab Automation Market is growing and government’s regulation and policies are helping in extension of the market. Governments in the region are investing significantly in the modernization of laboratory facilities through grants and funding programs, which enable laboratories to adopt advanced automation technologies. For instance, the National Institutes of Health (NIH) and other federal agencies have launched initiatives to support the integration of cutting-edge automation in biomedical research. Additionally, there are policies focused on improving healthcare outcomes through the adoption of comprehensive diagnostic solutions, which include automated testing and analysis. Regulatory bodies are also establishing frameworks that encourage standardization and interoperability of lab automation systems, ensuring seamless integration and compliance.
The future of North America Lab Automation Market looks promising due to various factors such as continuous technological advancements and evolving laboratory needs. Innovations in artificial intelligence and machine learning are set to revolutionize laboratory automation, enabling predictive analytics and autonomous decision-making processes that further enhance efficiency and accuracy. The integration of blockchain technology for secure and transparent data handling is another emerging trend that could address concerns related to data privacy and security. Moreover, the rising trend of personalized medicine and genomics necessitates sophisticated automation systems capable of handling high-throughput and complex data analysis.
According to Ravi Bhandari, Research Head, 6Wresearch, United States is expected to grow significantly in coming years attributed to research and healthcare innovation, supported by substantial federal funding and private investment. The presence of a large number of research institutes, universities, and prominent pharmaceutical companies creates a fertile ground for the adoption of advanced lab automation technologies.
Lab automation software and informatics are expected to be the fastest-growing segment in coming years due to digitization and data integration in laboratories is accelerating the adoption of sophisticated software solutions that manage workflows, data analysis, and interconnectivity.
Drug discovery segment is projected to experience significant growth in the future attributed to rising demand for new therapeutics, coupled with advancements in high-throughput screening and computational chemistry, is driving the adoption of lab automation in drug discovery processes.
Biotechnology and pharmaceutical industries are forecasted to experience substantial growth in coming years attributed to the increasing complexity of drug development processes and the emphasis on personalized medicine, these industries are heavily investing in automated solutions to enhance efficiency, accuracy, and throughput.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Lab Automation Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Lab Automation Market Revenues & Volume, 2021 & 2031F |
3.3 North America Lab Automation Market - Industry Life Cycle |
3.4 North America Lab Automation Market - Porter's Five Forces |
3.5 North America Lab Automation Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Lab Automation Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.7 North America Lab Automation Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.8 North America Lab Automation Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Lab Automation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Lab Automation Market Trends |
6 North America Lab Automation Market, 2021 - 2031 |
6.1 North America Lab Automation Market, Revenues & Volume, By Product, 2021 - 2031 |
6.2 North America Lab Automation Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3 North America Lab Automation Market, Revenues & Volume, By End User, 2021 - 2031 |
7 United States Lab Automation Market, 2021 - 2031 |
7.1 United States Lab Automation Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2 United States Lab Automation Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3 United States Lab Automation Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Canada Lab Automation Market, 2021 - 2031 |
8.1 Canada Lab Automation Market, Revenues & Volume, By Product, 2021 - 2031 |
8.2 Canada Lab Automation Market, Revenues & Volume, By Application, 2021 - 2031 |
8.3 Canada Lab Automation Market, Revenues & Volume, By End User, 2021 - 2031 |
9 North America Lab Automation Market Key Performance Indicators |
10 North America Lab Automation Market - Opportunity Assessment |
10.1 North America Lab Automation Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Lab Automation Market Opportunity Assessment, By Product, 2021 & 2031F |
10.3 North America Lab Automation Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 North America Lab Automation Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Lab Automation Market - Competitive Landscape |
11.1 North America Lab Automation Market Revenue Share, By Companies, 2024 |
11.2 North America Lab Automation Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Company Profiles |
13 Recommendations |
14 Disclaimer |